VX-702 is a p38 mitogen-activated protein kinase (MAPK) inhibitor. VX-702 had no effect on platelet aggregation induced by any of the p38 MAPK agonists. VX-702 has potential use in the treatment of inflammation, rheumatoid arthritis and cardiovascular dis
Molecular Spectra
No Data Available
Click here to submit data
References
• Kuliopulos, A. et al.: Thromb. Haemost., 92, 1387 (2004)